CNS Pharmaceuticals to receive 50% of net sales on resulting anti-viral commercial products, including WP1122, in certain international markets
PR Newswire
HOUSTON, April 13, 2020
PR Newswire
HOUSTON, April 13, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey